
Preservative-free glaucoma drops with Gavin Docherty, ep 41
Nov 25, 2024 - 00:29:48
Radio and PodcastLive Radio & Podcasts
The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inh...
Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3) is an episode from Talking About Glaucoma (mp3) by Robert M Schertzer, MD, MEd, FRCSC. The goal of the late Dave Epstein was to find a drug...
This episode belongs to Talking About Glaucoma (mp3).
Use the player on this page to stream the episode online.
Published Jun 7, 2019, 00:12:13 long, audio available.
The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of research, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals…and we’re Talking About Glaucoma. Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts and tell your friends about it, so that it can reach more listeners. Drop me a line at podcast@iguy.org with your show ideas. ————————————————————————— Selected links: ————————————————————————— Production information: This episode was recorded March 2019 during the Annual Meeting of the American Glaucoma Society in San Francisco using two Shure SM58 microphones with a Marantz PMD661 digital recorder. Mixing and sound levelling were completed June 2019 on an iMac using Hindenberg Journalist Pro software. Narration was overdubbed using a Blue Yeti Microphone. Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care. Robert M Schertzer, MD, MEd, FRCSC podcast@iguy.org Twitter - or Blog - or Facebook - Office website - or Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr © 2019 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC ————————————————————————— Today’s guest: Richard A. Lewis, MD Sacramento Eye Consultants 1515 River Park Drive, Suite 100, Sacramento, CA 95815 Tel: 1-916-649-1515 rlewiseyemd@yahoo.com —————————————————————————
You can listen to Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3) online on Radio and Podcast. Open the player on this page to stream the available audio.
Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3) is an episode from Talking About Glaucoma (mp3) by Robert M Schertzer, MD, MEd, FRCSC.
This episode is 00:12:13 long.
This episode was published on Jun 7, 2019.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Talking About Glaucoma (mp3) when more episodes are available from the podcast feed.
You can listen to Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3) on this page when the episode audio is available from the podcast feed.
Ep 31 Talking About Glaucoma - 6Jun2019 LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3) is from Talking About Glaucoma (mp3) by Robert M Schertzer, MD, MEd, FRCSC.
Published Jun 7, 2019 and 00:12:13 long